Enzo Biochem Inc. (NYSE:ENZ)’s share price shot up 3.6% on Monday . The company traded as high as $5.80 and last traded at $5.80, with a volume of 72,428 shares traded. The stock had previously closed at $5.60.

Separately, Zacks Investment Research lowered shares of Enzo Biochem from a “buy” rating to a “hold” rating in a report on Tuesday, August 9th.

The company has a market capitalization of $263.70 million and a price-to-earnings ratio of 14.92. The firm’s 50 day moving average price is $6.34 and its 200 day moving average price is $5.48.

Enzo Biochem (NYSE:ENZ) last issued its earnings results on Wednesday, June 8th. The company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.02. The company earned $18.16 million during the quarter, compared to the consensus estimate of $24.50 million. During the same quarter in the prior year, the company earned ($0.07) earnings per share. Equities research analysts predict that Enzo Biochem Inc. will post ($0.23) earnings per share for the current year.

Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.